Get access

Serpins Inhibit the Toxicity of Amyloid Peptides


  • David Schubert

    Corresponding author
    1. Cellular Neurobiology Laboratory, The Salk Institute, PO Box 85800, San Diego, CA 92186, USA
    • David Schubert, as above

    Search for more papers by this author


The amyloid plaque in Alzheimer's disease (AD) contains numerous proteins, some of which may be relevant to the pathogenesis of the disease. The serine protease inhibitor α1-antichymotrypsin is specifically localized in AD plaques. It is shown here that α1-antichymotrypsin and several other serine protease inhibitors (serpins) inhibit the toxicity of amyloid peptides on primary cortical nerve cell cultures as well as a clonal cell line. This inhibition of toxicity is not mediated via the serpin enzyme complex receptor, the transferrin receptor, or by interference with the polymerization of amyloid fibrils. Since a variety of synthetic serine protease inhibitors mimic the effects of serpins on amyloid toxicity, it is likely that the antiprotease activities of serpins are responsible for their biological effects.